Anti-tuberculosis drug-induced liver injury
BMJ
.
2023 Oct 27:383:e074866.
doi: 10.1136/bmj-2023-074866.
Authors
Wei Shen Lim
1
,
Anthony Avery
2
,
Onn Min Kon
3
,
Martin Dedicoat
4
Affiliations
1
Respiratory Medicine, Nottingham University Hospitals NHS Trust, NG5 1PB, England UK weishen.lim@nuh.nhs.uk.
2
Faculty of Medicine & Health Sciences, University of Nottingham, NG7 2RD, England UK.
3
Chest & Allergy clinic, Imperial College Healthcare NHS Trust, St Mary's Hospital, London W2 1NY, England UK.
4
Department of Infection, University Hospitals Birmingham, Birmingham. B9 5SS, England, UK.
PMID:
37890885
DOI:
10.1136/bmj-2023-074866
No abstract available
MeSH terms
Antitubercular Agents / adverse effects
Chemical and Drug Induced Liver Injury* / etiology
Humans
Liver
Tuberculosis*
Substances
Antitubercular Agents